Affinage

STK36

Serine/threonine-protein kinase 36 · UniProt Q9NRP7

Length
1315 aa
Mass
144.0 kDa
Annotated
2026-06-10
100 papers in source corpus 6 papers cited in narrative 6 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 5/6 claims corpus-supported (83%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

STK36, the mammalian ortholog of Drosophila Fused, is a serine-threonine kinase with dual roles spanning Hedgehog signal transduction and motile cilia assembly (PMID:8861096, PMID:23907739). In Drosophila, fused acts genetically downstream of Hedgehog and Patched to transmit the Hh signal controlling dpp and engrailed expression, operating within the same pathway as Costal-2, Cubitus interruptus, and PKA without being epistatic to them (PMID:8861096). In mammals, STK36 enhances GLI-induced transcription, with the long human isoform selectively potentiating GLI2 activity, and its loss impairs Hedgehog signaling output (PMID:15268766). Its transcriptional contribution is controlled by the E3 ubiquitin ligase MID1, which ubiquitinates and proteasomally cleaves Fu to couple the MID1-PP2A complex to GLI3 regulation (PMID:25278022). Independently of its signaling role, STK36 is required for assembly of the central pair apparatus and orientation of motile cilia, localizing to motile cilia where it physically associates with the kinesin Kif27 at the cilium base and with central pair components Spag16 and Pcdp1 (PMID:23907739). Homozygous loss-of-function mutations in STK36 cause primary ciliary dyskinesia with a central pair defect, with the protein localizing between the radial spokes and central pair of the axoneme (PMID:28543983).

Mechanistic history

Synthesis pass · year-by-year structured walk · 6 steps
  1. 1996 High

    Established that Fused operates within the Hedgehog pathway to transmit the signal, fixing its genetic position downstream of Hh and Patched and clarifying its relationship to Costal-2, Ci, and PKA.

    Evidence Genetic epistasis using Drosophila imaginal disc mutations and ectopic Hh expression

    PMID:8861096

    Open questions at the time
    • Does not identify direct biochemical substrates of the kinase
    • Pathway position relative to Ci/Cos-2 left unresolved (same pathway but not epistatic)
    • No mammalian generalization addressed
  2. 2004 Medium

    Showed the human ortholog STK36 retains a transcriptional function, with isoform-specific potentiation of GLI2 but not GLI1, indicating the Drosophila signaling role extends to mammals at the level of GLI effectors.

    Evidence Splice isoform characterization by RT-PCR and luciferase reporter assays for GLI1/GLI2 in transient overexpression

    PMID:15268766

    Open questions at the time
    • Overexpression reporter assay only, no endogenous validation
    • Mechanism of GLI2-selective enhancement unknown
    • Did not reverse SUFU-mediated GLI inhibition, leaving the regulatory node undefined
  3. 2007 Low

    Extended GLI-enhancing activity to mouse Fu and provided loss-of-function support for a Hedgehog role in a cellular context.

    Evidence Mouse Fu cDNA cloning, Gli reporter overexpression, and RNAi knockdown in one cell line

    PMID:18600476

    Open questions at the time
    • Single RNAi experiment in one cell line without rescue or mutagenesis
    • Context-dependence of the Hedgehog requirement not delineated
    • No biochemical mechanism established
  4. 2013 High

    Revealed a Hedgehog-independent function for Fu in motile cilia, identifying it as essential for central pair assembly and cilia orientation and naming its direct structural partners.

    Evidence Conditional knockout mouse oviduct analysis, TEM of ciliary ultrastructure, immunofluorescence, and reciprocal Co-IP with Kif27, Spag16, and Pcdp1

    PMID:23907739

    Open questions at the time
    • Whether kinase catalytic activity is required for central pair assembly not tested
    • Order of recruitment of Kif27/Spag16/Pcdp1 unresolved
    • Relationship between ciliary and Hedgehog roles not reconciled
  5. 2014 High

    Defined how Fu protein levels are controlled, showing MID1 ubiquitinates and cleaves Fu to link the MID1-PP2A complex to GLI3 transcriptional output.

    Evidence Biochemical ubiquitination and proteasomal cleavage assays and MID1-Fu interaction studies in SHH-active cancer cells

    PMID:25278022

    Open questions at the time
    • Functional consequence of Fu cleavage products not characterized
    • Whether this regulation operates in cilia as well as signaling unknown
    • In vivo relevance of MID1-Fu axis not established
  6. 2017 Medium

    Connected STK36 loss directly to human disease, demonstrating that loss-of-function mutations cause primary ciliary dyskinesia with a central pair defect.

    Evidence Gene sequencing identifying homozygous STK36 mutations and TEM of respiratory epithelial cilia in an affected individual

    PMID:28543983

    Open questions at the time
    • Single patient/family with no functional rescue experiment
    • Precise axonemal position inferred, not directly mapped
    • Genotype-phenotype spectrum across patients undefined

Open questions

Synthesis pass · forward-looking unresolved questions
  • The catalytic substrates of STK36 kinase activity in both Hedgehog signaling and central pair assembly remain unidentified, leaving the mechanistic link between its enzymatic function and its two cellular roles open.
  • No phosphorylation substrate identified
  • Whether kinase activity is required for ciliary versus signaling functions untested
  • Structural basis of partner binding unknown

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0140096 catalytic activity, acting on a protein 2 GO:0140110 transcription regulator activity 2
Localization
GO:0005929 cilium 2
Pathway
R-HSA-162582 Signal Transduction 3 R-HSA-1852241 Organelle biogenesis and maintenance 2
Complex memberships
central pair apparatus

Evidence

Reading pass · 6 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1996 Drosophila fused (fu) is required to transmit the Hedgehog (Hh) signal in imaginal discs; fu mutations rescue phenotypes caused by ectopic hh expression or loss of patched (ptc) activity, placing fu genetically downstream of hh and ptc in the pathway controlling dpp expression. fu is also required for engrailed activation downstream of Hh, but fu mutations do not rescue phenotypes caused by abnormal ci, cos-2, or pkA activity, indicating fu acts in the same pathway as these components but is not epistatic to them. Genetic epistasis analysis using Drosophila imaginal disc mutations and ectopic Hh expression Mechanisms of development High 8861096
2004 The human FU gene (STK36) encodes at least two protein isoforms arising from alternative splicing, including a long form and a shorter isoform. The long FU isoform enhances GLI2-induced transcriptional activity but does not affect GLI1-induced transcription. FU did not reverse SUFU-mediated inhibition of GLI. RT-PCR/nested PCR to characterize splice isoforms; transient overexpression with luciferase transcriptional reporter assays for GLI1 and GLI2 activity BMC genomics Medium 15268766
2007 Mouse Fu (Stk36) can enhance Gli-induced transcription in transient overexpression assays similarly to human FU. In one cell line where mFu expression was reduced by RNAi, Hedgehog signaling was severely impaired, indicating mFu may have a role in Hedgehog signaling and Gli regulation in certain cellular contexts. cDNA cloning of mouse Fu; transient overexpression with Gli transcriptional reporter; RNAi knockdown with Hedgehog signaling readout Journal of cell communication and signaling Low 18600476
2013 Mouse Fused (Stk36) is required for central pair (CP) apparatus assembly and proper cilia orientation in motile cilia of the oviductal epithelium. Fu-deficient mouse oviducts show defects in CP construction and cilia orientation. Fu protein localizes to motile cilia and physically associates with kinesin Kif27 at the cilium base and with known central pair components Spag16 and Pcdp1. Conditional knockout mouse analysis (Fu-deficient); transmission electron microscopy of oviductal cilia ultrastructure; immunofluorescence localization; co-immunoprecipitation of Fu with Kif27, Spag16, and Pcdp1 Developmental dynamics : an official publication of the American Association of Anatomists High 23907739
2014 The E3 ubiquitin ligase MID1 catalyzes ubiquitination and proteasomal cleavage of Fu (STK36). MID1-mediated ubiquitination and cleavage of Fu is identified as a key element connecting the MID1-PP2A protein complex to GLI3 activity control in SHH-GLI signaling. Biochemical ubiquitination assays; proteasomal cleavage assays; interaction studies between MID1 and Fu in cancer cell lines with autonomous SHH signaling The Journal of biological chemistry High 25278022
2017 Homozygous loss-of-function mutations in STK36 cause primary ciliary dyskinesia (PCD) with a central pair defect in a human patient with situs solitus. Transmission electron microscopy of respiratory epithelial cells from the affected individual demonstrates that STK36 is required for cilia orientation, with a probable localization of STK36 between the radial spokes and central pair of the ciliary axoneme. Whole-exome/gene sequencing identifying homozygous STK36 mutations; transmission electron microscopy of respiratory epithelial cilia ultrastructure Human mutation Medium 28543983

Source papers

Stage 0 corpus · 100 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2006 Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery. Molecular cancer 192 16709241
2010 Effects of 5-FU. Advances in experimental medicine and biology 113 20738018
2019 FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression. Scientific reports 110 30728402
2018 Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells. Experimental & molecular medicine 99 30111797
2007 Drug resistance to 5-FU linked to reactive oxygen species modulator 1. Biochemical and biophysical research communications 99 17537404
1998 The role of dihydropyrimidine dehydrogenase (DPD) modulation in 5-FU pharmacology. Oncology (Williston Park, N.Y.) 92 9830621
2019 LncRNA NEAT1 knockdown attenuates autophagy to elevate 5-FU sensitivity in colorectal cancer via targeting miR-34a. Cancer medicine 86 31802650
2022 SHMT2-mediated mitochondrial serine metabolism drives 5-FU resistance by fueling nucleotide biosynthesis. Cell reports 85 35977477
2022 Kaempferol Can Reverse the 5-Fu Resistance of Colorectal Cancer Cells by Inhibiting PKM2-Mediated Glycolysis. International journal of molecular sciences 84 35408903
2024 tsRNA-GlyGCC promotes colorectal cancer progression and 5-FU resistance by regulating SPIB. Journal of experimental & clinical cancer research : CR 70 39153969
2016 5-FU targets rpL3 to induce mitochondrial apoptosis via cystathionine-β-synthase in colon cancer cells lacking p53. Oncotarget 70 27385096
2020 LncRNA NEAT1 remodels chromatin to promote the 5-Fu resistance by maintaining colorectal cancer stemness. Cell death & disease 64 33168814
2021 Theabrownin from Fu Brick Tea Exhibits the Thermogenic Function of Adipocytes in High-Fat-Diet-Induced Obesity. Journal of agricultural and food chemistry 60 34581185
2009 MTHFR polymorphisms and 5-FU-based adjuvant chemotherapy in colorectal cancer. Annals of oncology : official journal of the European Society for Medical Oncology 60 19465420
2011 Resistance of colorectal cancer cells to radiation and 5-FU is associated with MELK expression. Biochemical and biophysical research communications 58 21806965
1996 The fu gene discriminates between pathways to control dpp expression in Drosophila imaginal discs. Mechanisms of development 57 8861096
2015 Quercetin induces apoptosis and enhances 5-FU therapeutic efficacy in hepatocellular carcinoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 56 26628295
2017 Mutation of serine/threonine protein kinase 36 (STK36) causes primary ciliary dyskinesia with a central pair defect. Human mutation 55 28543983
2022 Regulation of thymidylate synthase: an approach to overcome 5-FU resistance in colorectal cancer. Medical oncology (Northwood, London, England) 49 36308643
2004 Formulation and characterization of Paclitaxel, 5-FU and Paclitaxel + 5-FU microspheres. International journal of pharmaceutics 42 15113618
2020 nal-IRI+5-FU/LV versus 5-FU/LV in post-gemcitabine metastatic pancreatic cancer: Randomized phase 2 trial in Japanese patients. Cancer medicine 41 33099898
2022 Resveratrol alleviated 5-FU-induced cardiotoxicity by attenuating GPX4 dependent ferroptosis. The Journal of nutritional biochemistry 38 36442718
2019 MiR-214 sensitizes human colon cancer cells to 5-FU by targeting Hsp27. Cellular & molecular biology letters 38 30915129
2013 Down-regulation of BAX gene during carcinogenesis and acquisition of resistance to 5-FU in colorectal cancer. Pathology oncology research : POR 36 24122668
2024 An RNA damage response network mediates the lethality of 5-FU in colorectal cancer. Cell reports. Medicine 34 39378883
2022 SNORD1C maintains stemness and 5-FU resistance by activation of Wnt signaling pathway in colorectal cancer. Cell death discovery 34 35422067
2019 Aspirin suppresses chemoresistance and enhances antitumor activity of 5-Fu in 5-Fu-resistant colorectal cancer by abolishing 5-Fu-induced NF-κB activation. Scientific reports 34 31729451
2016 CTGF enhances resistance to 5-FU-mediating cell apoptosis through FAK/MEK/ERK signal pathway in colorectal cancer. OncoTargets and therapy 34 27942222
2006 Regulation of Ci and Su(fu) nuclear import in Drosophila. Developmental biology 34 16595130
2023 Wei-fu-chun tablet halted gastric intestinal metaplasia and dysplasia associated with inflammation by regulating the NF-κB pathway. Journal of ethnopharmacology 32 37567428
2022 METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma. International journal of oncology 32 35856434
2021 CircFBXL5 promotes the 5-FU resistance of breast cancer via modulating miR-216b/HMGA2 axis. Cancer cell international 31 34281530
2017 MACC1 mediates chemotherapy sensitivity of 5-FU and cisplatin via regulating MCT1 expression in gastric cancer. Biochemical and biophysical research communications 31 28235486
2015 Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU. Oncotarget 31 25909168
2021 DCBLD2 Affects the Development of Colorectal Cancer via EMT and Angiogenesis and Modulates 5-FU Drug Resistance. Frontiers in cell and developmental biology 29 34095137
2015 AMPK activator AICAR promotes 5-FU-induced apoptosis in gastric cancer cells. Molecular and cellular biochemistry 29 26497305
2013 Fused (Stk36) is a ciliary protein required for central pair assembly and motile cilia orientation in the mammalian oviduct. Developmental dynamics : an official publication of the American Association of Anatomists 29 23907739
2003 Efficacy and toxicity of nedaplatin and 5-FU with radiation treatment for advanced esophageal carcinomas. Anticancer research 29 12926096
2023 Resveratrol Modulates Chemosensitisation to 5-FU via β1-Integrin/HIF-1α Axis in CRC Tumor Microenvironment. International journal of molecular sciences 28 36902421
2021 LEF1 silencing sensitizes colorectal cancer cells to oxaliplatin, 5-FU, and irinotecan. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 28 34474344
2020 Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapy. JCI insight 28 32213714
2020 5-FU inhibits migration and invasion of CRC cells through PI3K/AKT pathway regulated by MARCH1. Cell biology international 28 33085122
2019 BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers. The Journal of pathology 28 31518438
2014 Anticancer effect of bromelain with and without cisplatin or 5-FU on malignant peritoneal mesothelioma cells. Anti-cancer drugs 28 24366282
2024 c-Fos regulated by TMPO/ERK axis promotes 5-FU resistance via inducing NANOG transcription in colon cancer. Cell death & disease 27 38233377
2020 Inhibition of CDK1 Reverses the Resistance of 5-Fu in Colorectal Cancer. Cancer management and research 27 33177877
2019 Inhibition of protein FAK enhances 5-FU chemosensitivity to gastric carcinoma via p53 signaling pathways. Computational and structural biotechnology journal 25 31969973
2022 Mesenchymal stem cell‑derived exosomes loaded with 5‑Fu against cholangiocarcinoma in vitro. Molecular medicine reports 24 35543159
2021 Thymidylate synthase O-GlcNAcylation: a molecular mechanism of 5-FU sensitization in colorectal cancer. Oncogene 24 34845374
2022 Paraprobiotics and Postbiotics of Lactobacillus delbrueckii CIDCA 133 Mitigate 5-FU-Induced Intestinal Inflammation. Microorganisms 23 35889136
2020 Lactobacillus-derived metabolites enhance the antitumor activity of 5-FU and inhibit metastatic behavior in 5-FU-resistant colorectal cancer cells by regulating claudin-1 expression. Journal of microbiology (Seoul, Korea) 23 33125671
2016 B7-H3 upregulates BRCC3 expression, antagonizing DNA damage caused by 5-Fu. Oncology reports 23 27175567
2019 MiR-195 reverses 5-FU resistance through targeting HMGA1 in gastric cancer cells. European review for medical and pharmacological sciences 22 31115003
2014 Expression of ABCB6 is related to resistance to 5-FU, SN-38 and vincristine. Anticancer research 22 25202056
2014 The E3 ubiquitin ligase MID1 catalyzes ubiquitination and cleavage of Fu. The Journal of biological chemistry 22 25278022
2016 DKK4 enhances resistance to chemotherapeutics 5-Fu and YN968D1 in colorectal cancer cells. Oncology letters 20 28356933
2024 ALKBH4 impedes 5-FU Sensitivity through suppressing GSDME induced pyroptosis in gastric cancer. Cell death & disease 19 38902235
2023 KLF4 targets RAB26 and decreases 5-FU resistance through inhibiting autophagy in colon cancer. Cancer biology & therapy 19 37431852
2024 Chinese medicinal formula Fu Xin decoction against chronic heart failure by inhibiting the NLRP3/caspase-1/GSDMD pyroptotic pathway. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 18 38599064
2021 Nuclear Translocation of SRPKs Is Associated with 5-FU and Cisplatin Sensitivity in HeLa and T24 Cells. Cells 18 33808326
2021 CMPK1 Regulated by miR-130b Attenuates Response to 5-FU Treatment in Gastric Cancer. Frontiers in oncology 18 33816278
2021 Pharmacokinetics of preoperative intraperitoneal 5-FU in patients with pancreatic ductal adenocarcinoma. Cancer chemotherapy and pharmacology 18 34132895
2025 FOXC1-mediated serine metabolism reprogramming enhances colorectal cancer growth and 5-FU resistance under serine restriction. Cell communication and signaling : CCS 17 39773485
2024 Super-enhancer Activates Master Transcription Factor NR3C1 Expression and Promotes 5-FU Resistance in Gastric Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 17 39731339
2022 LINC02418 upregulates EPHA2 by competitively sponging miR-372-3p to promote 5-Fu/DDP chemoresistance in colorectal cancer. Carcinogenesis 17 35914269
2013 The noncytotoxic dose of sorafenib sensitizes Bel-7402/5-FU cells to 5-FU by down-regulating 5-FU-induced Nrf2 expression. Digestive diseases and sciences 17 23314856
2011 A predicted protein, KIAA0247, is a cell cycle modulator in colorectal cancer cells under 5-FU treatment. Journal of translational medicine 17 21619678
2007 A possible role of mouse Fused (STK36) in Hedgehog signaling and Gli transcription factor regulation. Journal of cell communication and signaling 17 18600476
1981 The target cell determinants of the antitumor actions of 5-FU: does FU incorporation into RNA play a role? Cancer treatment reports 17 6179616
2025 Low miR-224-5p in exosomes confers colorectal cancer 5-FU resistance by upregulating S100A4. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 16 39956015
2022 Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRASG12D glycolytic colorectal tumors. Communications biology 16 36316440
2021 HDAC6 inhibitor WT161 performs anti-tumor effect on osteosarcoma and synergistically interacts with 5-FU. Bioscience reports 16 33860796
2021 Knockdown of circNRIP1 sensitizes colorectal cancer to 5‑FU via sponging miR‑532‑3p. Oncology reports 16 34396434
2020 Cannabidiol on 5-FU-induced oral mucositis in mice. Oral diseases 16 32400905
2020 miR-149 contributes to resistance of 5-FU in gastric cancer via targeting TREM2 and regulating β-catenin pathway. Biochemical and biophysical research communications 16 32977944
2020 Targeting REV7 effectively reverses 5-FU and oxaliplatin resistance in colorectal cancer. Cancer cell international 16 33292253
2019 Imatinib inhibits the regrowth of human colon cancer cells after treatment with 5-FU and cooperates with vitamin D analogue PRI-2191 in the downregulation of expression of stemness-related genes in 5-FU refractory cells. The Journal of steroid biochemistry and molecular biology 16 30772447
2022 Effects of Fu's subcutaneous needling on mitochondrial structure and function in rats with sciatica. Molecular pain 15 35670088
2020 Combinational inhibition of EGFR and YAP reverses 5-Fu resistance in colorectal cancer. Journal of Cancer 15 32742490
2016 Targeting PCDH20 gene by microRNA-122 confers 5-FU resistance in hepatic carcinoma. American journal of cancer research 15 27648358
2009 Enhanced cytotoxicity of 5-FU by bFGF through up-regulation of uridine phosphorylase 1. Molecules and cells 15 19714313
2024 5-FU promotes HBV replication through oxidative stress-induced autophagy dysfunction. Free radical biology & medicine 14 38215891
2021 Joint Belgian recommendation on screening for DPD-deficiency in patients treated with 5-FU, capecitabine (and tegafur). Acta clinica Belgica 14 33423619
2021 Long noncoding RNA CRART16 confers 5-FU resistance in colorectal cancer cells by sponging miR-193b-5p. Cancer cell international 14 34844630
2020 Over-expression of EGFR regulated by RARA contributes to 5-FU resistance in colon cancer. Aging 14 31896739
2019 MiR-335 promotes cell proliferation by inhibiting MEF2D and sensitizes cells to 5-Fu treatment in gallbladder carcinoma. European review for medical and pharmacological sciences 14 31799650
2017 NSC30049 inhibits Chk1 pathway in 5-FU-resistant CRC bulk and stem cell populations. Oncotarget 14 28915668
2025 KLF6-mediated recruitment of the p300 complex enhances H3K23su and cooperatively upregulates SEMA3C with FOSL2 to drive 5-FU resistance in colon cancer cells. Experimental & molecular medicine 13 40082673
2025 Pectolinarigenin mitigates 5-FU-induced intestinal mucositis via suppressing ferroptosis through activating PPARγ/GPX4 signaling. Phytomedicine : international journal of phytotherapy and phytopharmacology 13 40414047
2025 Targeting the JAK2-STAT3-UCHL3-ENO1 axis suppresses glycolysis and enhances the sensitivity to 5-FU chemotherapy in TP53-mutant colorectal cancer. Acta pharmaceutica Sinica. B 13 40487654
2022 Genome-wide CRISPR Screening Reveals Pyrimidine Metabolic Reprogramming in 5-FU Chronochemotherapy of Colorectal Cancer. Frontiers in oncology 13 35903686
2022 Synthesis and Chemopreventive Potential of 5-FU/Genistein Hybrids on Colorectal Cancer Cells. Pharmaceuticals (Basel, Switzerland) 13 36297411
2012 TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells. Anatomical record (Hoboken, N.J. : 2007) 13 23125179
2004 The FU gene and its possible protein isoforms. BMC genomics 13 15268766
1998 Irinotecan plus 5-FU and leucovorin in advanced colorectal cancer: North American trials. Oncology (Williston Park, N.Y.) 13 9726093
2019 H1, a derivative of tetrandrine, enhances the efficacy of 5-FU in Bel7402/5-FU cells via suppressing STAT3/MCL-1 and inducing PUMA. Biochemical and biophysical research communications 12 31582208
2023 Hungatella hathewayi impairs the sensitivity of colorectal cancer cells to 5-FU through decreasing CDX2 expression. Human cell 11 37477870
2023 Vactosertib potently improves anti-tumor properties of 5-FU for colon cancer. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 11 37740873
2022 Development of 5-FU-modified tumor suppressor microRNAs as a platform for novel microRNA-based cancer therapeutics. Molecular therapy : the journal of the American Society of Gene Therapy 11 35933584
2019 BET inhibitor bromosporine enhances 5-FU effect in colorectal cancer cells. Biochemical and biophysical research communications 11 31708100

Missed literature

Know a paper Affinage missed for STK36? Flag it for the maintainers and the community.

No submissions yet.